NRG1 overexpression was significantly associated with aggressive features, including infiltrative tumor growth, lymphovascular and neural invasion, a high pathologic stage and poor prognosis, but it was not associated with the presence of EBV, MSI or HER2 status. The gene discussed is NRG1; the disease is neoplasm.